Evvy
8 known investors
Evvy is an AI-powered precision medicine platform using vaginal microbiome testing and analysis to diagnose and treat women's health conditions including vaginal health, fertility, and menopause. The platform translates vaginal microbiome data into personalized care pathways and novel biomarker discovery for women who have historically been excluded from clinical research.
AI & Machine LearningDigital HealthFemTechHealthtech
Founders & leadership
Investors · 8
Amboy Street VenturesVenice
Foreground CapitalBoston
Ingeborg InvestmentsWashingtonvia Anna Mason · inferred
Left Lane CapitalNew York · $5M – $75M
Virtue VenturesAustin · $500K – $2Mvia Sean Doolan · inferred
BBG VenturesreportedNew York · $500K – $1M
General CatalystreportedSan Francisco · $30M
Human VenturesreportedNew York
In the news
- Juno Bio Raises $3.8M to Expand Vaginal Microbiome Testing | Fitt Insiderinsider.fitt.co · 2026
- Evvy prepares to raise future financing amid vaginal treatment expansion - Crain's New York Businesscrainsnewyork.com · 2025
- Evvy raises profile of the vaginal microbiomenutraingredients.com · 2024
- Evvy, Precision Women’s Health Startup focused on the Vaginal Microbiome, Announces $14M Series A - Microbiome Times Magazinemicrobiometimes.com · 2023
- Evvy CEO Priyanka Jain Talks Series A Funding, How Evvy Uses Artificial Intelligence To Make Vaginal Health More Accessible To All Womenforbes.com · 2023